Fresenius Medical Care AG & Co. KGaA (FME.XETRA)

Exchange: XETRA Exchange
Currency: EUR

Price: 60.34 (Close)



52 Week range 200d Moving Avg. Beta
50.98 – 71.14 61.49 0.98
Dividend Dividend Yield Ex-Dividend date
1.35 2.24% 2022-05-13
P/E Ratio Latest EPS DGR 3 years
18.24 3.31 8.13%
Near Fair Value
Average Volatility
Dividend Growth


Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2018, it operated 3,928 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.


Sector: Industry:
Healthcare Medical Care

Environment, Social and Governance (ESG) Ratings

Total ESG Score

18 – 16 percentile


0 – 0 percentile


3 – 0 percentile


10 – 0 percentile

Controversy level



see MSCI ESG rating explained

Dividend Safety Metrics

Latest EPS 3.31
Annual Payout 1.35
Payout Ratio 40.79%
Dividend growth 24 Years
Dividend Score 79
Dividend Coverage Ratio 2.45
Altman-Z score 0.00


Fresenius Medical Care AG & Co. KGaA (FME.XETRA) Valuation

Fresenius Medical Care AG & Co. KGaA’s current dividend yield of 2.24% is 5% just above its 5-year average. The 5-year average dividend yield is 2.12% (see red-line in chart). This indicates the stock looks reasonably valued today.

Fresenius Medical Care AG & Co. KGaA (FME.XETRA) Performance

The chart below displays the total price return(%) of Fresenius Medical Care AG & Co. KGaA for different periods:


Fresenius Medical Care AG & Co. KGaA (FME.XETRA) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Fresenius Medical Care AG & Co. KGaA for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
2.24 1.35 40.79% 24 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) 8.13%
5 Year Growth Rate (CAGR) 10.87%
10 Year Growth Rate (CAGR) 7.50%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2021 1.340 11.7%
2020 1.200 -48.7%
2019 2.340 120.8%
2018 1.060 10.4%
2017 0.960 20.0%
2016 0.800 2.6%
2015 0.780 1.3%
2014 0.770 2.7%
2013 0.750 8.7%
2012 0.690 6.2%
2011 0.650 6.6%
2010 0.610 5.2%
2009 0.580 7.4%
2008 0.540 14.9%

Fresenius Medical Care AG & Co. KGaA (FME.XETRA) Dividend Payment History